A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans.
The export of virulence factors, such as the capsule polysaccharide, to the cell surface is a critical aspect of the pathogenicity of Cryptococcus neoformans. A view of capsule export via exocytosis and extracellular vesicles is emerging, but the molecular mechanisms underlying virulence factor transport pathways remain to be established. In this study, we characterized the APT1 gene, which encodes a predicted integral membrane P-type ATPase belonging to the type IV, Drs2 family of aminophospholipid translocases (flippases) (APTs). APTs maintain the phospholipid asymmetry that is critical in membrane fusion events for trafficking and in establishing cell polarity. Deletion of the APT1 gene resulted in phenotypes consistent with similar roles in C. neoformans. These included altered actin distribution, increased sensitivity to stress conditions (oxidative and nitrosative stress) and to trafficking inhibitors, such as brefeldin A and monensin, a reduction in exported acid phosphatase activity, and hypersensitivity to the antifungal drugs amphotericin B, fluconazole, and cinnamycin. However, there was no difference in growth, capsule size, or melanin production between the wild type and the apt1 mutant strains at either 30 degrees C or 37 degrees C. Despite the absence of an influence on these major virulence factors, Apt1 was required for survival during interactions with macrophages, and apt1 mutants exhibited attenuated virulence in a mouse inhalation model of cryptococcosis. Therefore, Apt1 contributes to virulence and the stress response in C. neoformans through apparent functions in membrane fusion and trafficking that do not influence the deposition of major virulence factors, such as capsule and melanin, outside the cell.
Hu
Guanggan
G
University of British Columbia, Michael Smith Laboratories, Department of Microbiology and Immunology, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.
Kronstad
James W
JW
D000199:Actins / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000235:genetics / Q000378:metabolism*; D000666:Amphotericin B / Q000378:metabolism; D000818:Animals; D000935:Antifungal Agents / Q000378:metabolism; D001430:Bacteriocins / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D003453:Cryptococcosis / Q000378:metabolism; D003455:Cryptococcus neoformans / Q000166:cytology / Q000201:enzymology* / Q000472:pathogenicity* / Q000502:physiology*; D004705:Endocytosis / Q000502:physiology; D005260:Female; D015725:Fluconazole / Q000378:metabolism; D005656:Fungal Proteins / Q000235:genetics / Q000378:metabolism*; D005816:Genetic Complementation Test; D006801:Humans; D008264:Macrophages / Q000378:metabolism; D008543:Melanins / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D018384:Oxidative Stress; D010456:Peptides, Cyclic / Q000378:metabolism; D049294:Phospholipid Transfer Proteins / Q000235:genetics / Q000378:metabolism*; D037521:Virulence Factors / Q000235:genetics / Q000378:metabolism
D000199:Actins; D000935:Antifungal Agents; D001430:Bacteriocins; D005656:Fungal Proteins; D008543:Melanins; D010456:Peptides, Cyclic; D049294:Phospholipid Transfer Proteins; D037521:Virulence Factors; C000485:cinnamycin; D000666:Amphotericin B; D015725:Fluconazole; D000251:Adenosine Triphosphatases